BackFidelity Select Biotechnology Portfolio Overview

Fidelity Select Biotechnology Portfolio Net Tangible Assets

Track Fidelity Select Biotechnology Portfolio's net tangible assets ($180M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$178.83M
↑ 0.11% YoYΔ $201592.00 vs prior year quarter

Peer average

Loading

Fidelity Select Biotechnology Portfolio Net Tangible Assets History

Loading

Fidelity Select Biotechnology Portfolio vs. peers: Net Tangible Assets Comparison

Loading

Fidelity Select Biotechnology Portfolio Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Fidelity Select Biotechnology Portfolio (FBIOX) FAQ

As of the most recent data (September 2023), FBIOX shows a net tangible assets of $180M. That compares with $180M in the prior-year period — up 0.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, FBIOX's net tangible assets is now $180M (was $180M) — a 0.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Fidelity Select Biotechnology Portfolio is outperforming or lagging.

Tracking FBIOX's net tangible assets over time shows whether Fidelity Select Biotechnology Portfolio is scaling, shrinking, or reshaping that part of the business. The current reading is $180M That compares with $180M in the prior-year period — up 0.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Fidelity Select Biotechnology Portfolio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $180M) with ownership activity and broader fundamentals.